FDA Decision On Interchangeable Exclusivity Allows Pfizer To Rival Boehringer On Adalimumab

Humira Biosimilar Abrilada Is Now Interchangeable; Pfizer Reveals Launch And Pricing Details

 
• By David Wallace
  
Hourglass timer dissolving, end of time period concept
The FDA decision has ended Boehringer’s exclusivity period • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products